We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
William Tatum IV

William O Tatum IV DO

Consultant and Professor of Neurology, Mayo Clinic Florida, Jacksonville, Florida

Dr. William O. Tatum IV is professor in the Mayo Clinic College of Medicine, and senior consultant in the Department of Neurology at Mayo Clinic Florida. He is a Fellow in the American Academy of Neurology, American Neurological Association and the American Clinical Neurophysiology Society. He is board-certified in Neurology, Clinical Neurophysiology, and Epilepsy and serves as the current director for the Comprehensive Epilepsy Center and Epilepsy Monitoring Unit at the Mayo Clinic in Florida. He completed his medical education at the College of Osteopathic Medicine and Surgery in Des Moines, Iowa, neurology residency at Loyola University Medical Center in Chicago, Illinois, and a two-year epilepsy fellowship at Graduate Hospital affiliated with the University of Pennsylvania. After training, he relocated to Tampa, Florida pioneering Tampa General Hospital-University of South Florida Comprehensive Epilepsy Center before joining the Mayo Clinic in 2009 as a clinician-educator.

He is a past president of the board of the American Board of Clinical Neurophysiology and the American Clinical Neurophysiology Society, currently serving as the Chair for the clinical neurophysiology section of the American Academy of Neurology. He has served on the board of directors for the American Board of Registration of EEG Technologists and Evoked Potentials, and currently serves on the board of the Epilepsy Foundation of America. He has been principal investigator in pharmacologic and device clinical trials with research interests in drug-resistant epilepsy, seizure semiology and EEG/clinical neurophysiology. He has authored >180 peer-reviewed manuscripts, 35 book chapters and edited/co-edited 8 books in the field of epilepsy and clinical neurophysiology. He serves on the current editorial board for the Journal of Clinical Neurophysiology as Associate Editor and is the Editor-in-Chief for Epilepsy and Behavior Reports. He has presented lectures at national and international meetings as an invited lecturer.

Disclosures

Dr. Tatum discloses the following:

  • Personal compensation: Stipend, Editor-in-Chief, Epilepsy Behavior Case Report (journal);
  • Editorial Board: Journal Clinical Neurophysiology;
  • Consultant: BioSerenity/DigiTrace Care Services, Inc., SK Life Science (Safety Board);
  • Patents held or pending: #62527896; #62770362 (intraoperative monitoring sensor devices);
  • Royalties from publishing:  Demos Publishers Inc., Springer Publishing;
  • Honoraria for speaking engagements: American Academy of Neurology, American Epilepsy Society, American Clinical Neurophysiology Society;  
  • Research support: Yes, Mayo Clinic, Esai (pending), Engage, Liva Nova, Martin Family Foundation 
  • Leadership positions: American Academy of Neurology (Section Head Clinical Neurophysiology); Epilepsy Foundation of American (National Professional Advisory Board Member); ex-officio American Clinical Neurophysiology Society and American Board of Clinical Neurophysiology.